BiondVax Pharmaceuticals Price History

BVXVDelisted Stock  USD 1.35  0.03  2.17%   
If you're considering investing in BiondVax Stock, it is important to understand the factors that can impact its price. As of today, the current price of BiondVax Pharmaceuticals stands at 1.35, as last reported on the 28th of December, with the highest price reaching 1.40 and the lowest price hitting 1.34 during the day. We have found twenty-three technical indicators for BiondVax Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm BiondVax Pharmaceuticals' Standard Deviation of 3.6, mean deviation of 2.62, and Risk Adjusted Performance of (0.13) to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
BiondVax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
BVXV
Based on monthly moving average BiondVax Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BiondVax Pharmaceuticals by adding BiondVax Pharmaceuticals to a well-diversified portfolio.

BiondVax Pharmaceuticals Stock Price History Chart

There are several ways to analyze BiondVax Stock price data. The simplest method is using a basic BiondVax candlestick price chart, which shows BiondVax Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

BiondVax Stock Price History Data

The price series of BiondVax Pharmaceuticals for the period between Sun, Sep 29, 2024 and Sat, Dec 28, 2024 has a statistical range of 0.8 with a coefficient of variation of 14.67. The prices are distributed with arithmetic mean of 1.64. The median price for the last 90 days is 1.59. The company had 1:10 stock split on 25th of November 2022.
OpenHighLowCloseVolume
12/28/2024
 1.38  1.40  1.34  1.35 
07/24/2023 1.38  1.40  1.34  1.35  17,962 
07/21/2023 1.44  1.49  1.33  1.39  19,122 
07/20/2023 1.49  1.55  1.43  1.44  36,281 
07/19/2023 1.46  1.48  1.46  1.46  12,129 
07/18/2023 1.52  1.52  1.44  1.46  13,331 
07/17/2023 1.50  1.52  1.45  1.46  13,469 
07/14/2023 1.56  1.56  1.45  1.45  13,518 
07/13/2023 1.54  1.63  1.49  1.49  38,194 
07/12/2023 1.43  1.87  1.43  1.59  507,724 
07/11/2023 1.40  1.44  1.40  1.43  17,451 
07/10/2023 1.42  1.45  1.39  1.41  27,143 
07/07/2023 1.41  1.41  1.37  1.38  5,972 
07/06/2023 1.38  1.43  1.37  1.39  11,831 
07/05/2023 1.43  1.43  1.39  1.39  13,734 
07/03/2023 1.38  1.45  1.37  1.41  10,600 
06/30/2023 1.33  1.42  1.33  1.41  28,182 
06/29/2023 1.36  1.39  1.32  1.36  21,133 
06/28/2023 1.37  1.41  1.37  1.39  10,661 
06/27/2023 1.43  1.46  1.36  1.40  11,139 
06/26/2023 1.36  1.43  1.33  1.41  29,182 
06/23/2023 1.47  1.48  1.33  1.34  73,385 
06/22/2023 1.38  1.49  1.37  1.47  18,133 
06/21/2023 1.40  1.41  1.31  1.41  24,754 
06/20/2023 1.46  1.46  1.40  1.42  30,329 
06/16/2023 1.42  1.47  1.39  1.46  57,821 
06/15/2023 1.36  1.40  1.34  1.39  40,205 
06/14/2023 1.36  1.36  1.30  1.35  28,376 
06/13/2023 1.37  1.37  1.29  1.34  39,920 
06/12/2023 1.36  1.36  1.30  1.34  36,972 
06/09/2023 1.42  1.44  1.32  1.35  61,732 
06/08/2023 1.37  1.48  1.37  1.42  52,300 
06/07/2023 1.46  1.49  1.36  1.42  119,279 
06/06/2023 1.48  1.57  1.31  1.43  368,614 
06/05/2023 2.08  2.27  1.52  1.53  7,857,930 
06/02/2023 1.70  1.78  1.70  1.70  8,500 
06/01/2023 1.78  1.78  1.70  1.70  11,716 
05/31/2023 1.88  1.88  1.72  1.77  13,494 
05/30/2023 1.90  1.90  1.84  1.86  6,518 
05/26/2023 1.82  1.86  1.82  1.82  2,386 
05/25/2023 1.87  1.90  1.82  1.82  4,541 
05/24/2023 1.80  1.90  1.80  1.90  1,888 
05/23/2023 1.90  1.92  1.81  1.84  12,469 
05/22/2023 1.85  1.90  1.81  1.85  4,955 
05/19/2023 1.77  1.87  1.77  1.87  3,849 
05/18/2023 1.83  1.90  1.79  1.81  6,528 
05/17/2023 1.81  1.84  1.76  1.84  2,887 
05/16/2023 1.77  1.85  1.77  1.81  7,738 
05/15/2023 1.76  1.87  1.76  1.83  4,102 
05/12/2023 1.78  1.89  1.78  1.89  9,488 
05/11/2023 1.86  1.86  1.80  1.80  15,476 
05/10/2023 1.94  1.94  1.86  1.86  17,093 
05/09/2023 1.90  1.94  1.90  1.94  7,194 
05/08/2023 2.00  2.00  1.90  1.94  7,596 
05/05/2023 1.99  2.00  1.91  1.94  15,504 
05/04/2023 1.91  1.96  1.90  1.92  12,200 
05/03/2023 1.92  1.98  1.81  1.89  15,547 
05/02/2023 1.86  1.89  1.81  1.81  19,096 
05/01/2023 1.86  1.96  1.84  1.87  11,742 
04/28/2023 2.01  2.01  1.91  1.93  7,796 
04/27/2023 1.95  1.99  1.90  1.98  6,511 

About BiondVax Pharmaceuticals Stock history

BiondVax Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BiondVax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BiondVax Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BiondVax Pharmaceuticals stock prices may prove useful in developing a viable investing in BiondVax Pharmaceuticals
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. Biondvax Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.

BiondVax Pharmaceuticals Stock Technical Analysis

BiondVax Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of BiondVax Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BiondVax Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run USA ETFs Now

   

USA ETFs

Find actively traded Exchange Traded Funds (ETF) in USA
All  Next Launch Module

BiondVax Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for BiondVax Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of BiondVax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BiondVax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in BiondVax Stock

If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
CEOs Directory
Screen CEOs from public companies around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamental Analysis
View fundamental data based on most recent published financial statements
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges